Logo image of EUDA

EUDA HEALTH HOLDINGS LTD (EUDA) Stock Fundamental Analysis

NASDAQ:EUDA - VGG3142E1051 - Common Stock

2.06 USD
-0.15 (-7%)
Last: 8/29/2025, 8:18:57 PM
2.07 USD
+0.01 (+0.49%)
After Hours: 8/29/2025, 8:18:57 PM
Fundamental Rating

1

Overall EUDA gets a fundamental rating of 1 out of 10. We evaluated EUDA against 102 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of EUDA have multiple concerns. EUDA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year EUDA has reported negative net income.
In the past year EUDA has reported a negative cash flow from operations.
EUDA had negative earnings in 4 of the past 5 years.
In the past 5 years EUDA always reported negative operating cash flow.
EUDA Yearly Net Income VS EBIT VS OCF VS FCFEUDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

EUDA has a worse Return On Assets (-904.54%) than 98.04% of its industry peers.
Industry RankSector Rank
ROA -904.54%
ROE N/A
ROIC N/A
ROA(3y)-557.55%
ROA(5y)-334.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EUDA Yearly ROA, ROE, ROICEUDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

The Gross Margin of EUDA (19.00%) is comparable to the rest of the industry.
The Profit Margin and Operating Margin are not available for EUDA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EUDA Yearly Profit, Operating, Gross MarginsEUDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

0

2. Health

2.1 Basic Checks

EUDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EUDA has been increased compared to 1 year ago.
The debt/assets ratio for EUDA has been reduced compared to a year ago.
EUDA Yearly Shares OutstandingEUDA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
EUDA Yearly Total Debt VS Total AssetsEUDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

EUDA has an Altman-Z score of -35.55. This is a bad value and indicates that EUDA is not financially healthy and even has some risk of bankruptcy.
EUDA's Altman-Z score of -35.55 is on the low side compared to the rest of the industry. EUDA is outperformed by 93.14% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -35.55
ROIC/WACCN/A
WACC8.74%
EUDA Yearly LT Debt VS Equity VS FCFEUDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

EUDA has a Current Ratio of 0.18. This is a bad value and indicates that EUDA is not financially healthy enough and could expect problems in meeting its short term obligations.
EUDA's Current ratio of 0.18 is on the low side compared to the rest of the industry. EUDA is outperformed by 93.14% of its industry peers.
A Quick Ratio of 0.15 indicates that EUDA may have some problems paying its short term obligations.
The Quick ratio of EUDA (0.15) is worse than 92.16% of its industry peers.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.15
EUDA Yearly Current Assets VS Current LiabilitesEUDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for EUDA have decreased by -9.30% in the last year.
Looking at the last year, EUDA shows a quite strong growth in Revenue. The Revenue has grown by 8.22% in the last year.
EPS 1Y (TTM)-9.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.3%
Revenue 1Y (TTM)8.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%8.22%

3.2 Future

The Earnings Per Share is expected to grow by 53.74% on average over the next years. This is a very strong growth
EUDA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 168.04% yearly.
EPS Next Y66.67%
EPS Next 2Y53.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year102.75%
Revenue Next 2Y168.04%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

EUDA Yearly Revenue VS EstimatesEUDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2023 2024 2025 2026 10M 20M 30M 40M
EUDA Yearly EPS VS EstimatesEUDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0 0.1 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

EUDA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EUDA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EUDA Price Earnings VS Forward Price EarningsEUDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EUDA Per share dataEUDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2 -0.3 -0.4

4.3 Compensation for Growth

EUDA's earnings are expected to grow with 53.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.74%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EUDA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EUDA HEALTH HOLDINGS LTD

NASDAQ:EUDA (8/29/2025, 8:18:57 PM)

After market: 2.07 +0.01 (+0.49%)

2.06

-0.15 (-7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)06-14 2024-06-14
Earnings (Next)N/A N/A
Inst Owners2.25%
Inst Owner Change1.13%
Ins Owners18.48%
Ins Owner Change0%
Market Cap76.55M
Analysts82.86
Price Target6.12 (197.09%)
Short Float %0.05%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 19.08
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.11
BVpS-0.07
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -904.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19%
FCFM N/A
ROA(3y)-557.55%
ROA(5y)-334.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.36
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.97%
Cap/Sales 2.89%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.18
Quick Ratio 0.15
Altman-Z -35.55
F-Score3
WACC8.74%
ROIC/WACCN/A
Cap/Depr(3y)24.68%
Cap/Depr(5y)21.79%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.3%
EPS Next Y66.67%
EPS Next 2Y53.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%8.22%
Revenue Next Year102.75%
Revenue Next 2Y168.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.27%
OCF growth 3YN/A
OCF growth 5YN/A